However, all the larvae had different kind of malformations. Finally, in order to improve the results obtained at -20 °C, the CSs were incorporated into the embryos by microinjection. In this case, it was observed that the most convenient combination was the microinjection of S2 (same composition as S1 but without Me2SO) in the perivitelline space followed by rapid cooling. Although the hatching rate was not improved (67.93 ± 8.31%), the microinjection allowed to obtain at least 4.5% normal-looking larvae. These results showed that the cooling of pejerrey embryos at zub-zero temperatures was feasible. Moreover, the microinjection of cryoprotectants within the pejerrey O.bonariensis embryos was employed for the first time in this species. The objectives of this study were to (1) characterize the variability for sire's predicted transmitting ability (PTA) for daughter's pregnancy rate (DPR) and cow conception rate (CCR), (2) determine the relationships among sire's PTA for DPR, sire's PTA for CCR, daughter's parity, and daughter's 305-d mature-equivalent (ME) milk production, and (3) evaluate the associations among sire's PTA for DPR and CCR and daughter's reproductive performance [pregnancy to first artificial insemination (P/AI), pregnancy by 150 d in milk (PR150) and pregnancy loss (PL) after first AI] in Canadian Holstein cows. The data were obtained from 822 lactating Holstein cows from 10 commercial dairy herds located in Alberta. Overall mean (range) for sire's PTA for DPR and CCR was -0.09 (-9.6 to 8.2) and -0.05 (-9.9 to 7.4), respectively. Sire's PTA for DPR was strongly and positively associated with sire's PTA for CCR (r = 0.89; P  less then  0.01). Sire's PTA for DPR and CCR were weakly and negatively associated with parity (r = -0ghly variable and positively correlated. Sire's PTA for DPR was associated with daughter's P/AI and PR150, but sire's PTA for CCR was not associated with any of the measured reproductive outcomes. Therefore, selecting sires with high PTA for DPR has the potential to improve the reproductive efficiency of Canadian dairy herds. Crown All rights reserved.Extracellular vesicles (EVs) are membrane-bound biological nanoparticles (NPs) and have gained wide attention as potential biomarkers. We aimed to isolate and characterize EVs from media conditioned by individually cultured preimplantation bovine embryos and to assess their relationship with embryo quality. Presumptive zygotes were cultured individually in 60 μl droplets of culture media, and 50 μl of media were collected from the droplets either on day 2, 5 or 8 post-fertilization. After sampling, the embryo cultures were continued in the remaining media until day 8, and the embryo development was evaluated at day 2 (cleavage), day 5 (morula stage) and day 8 (blastocyst stage). EVs were isolated using qEVsingle® columns and characterized. Based on EV Array, EVs isolated from embryo conditioned media were strongly positive for EV-markers CD9 and CD81 and weakly positive for CD63 and Alix among others. They had a cup-like shape typical to EVs as analyzed by transmission electron microscopy and spherical shape pective development potential. BACKGROUND In patients with multiple sclerosis (MS), development of hepatic injury has been sporadically reported after methylprednisolone (MP) pulse therapy. Some studies suggest autoimmune hepatitis, while other studies reported direct hepatotoxicity as a cause for hepatic injury. Here, we studied the pathological mechanism of such liver injury in patients with MS. METHODS From 2005 to 2016, eight patients with MS developed liver injury after MP pulse therapy. Their average age was 38 years (range 28-49 years, all female). JDQ443 solubility dmso Autoimmune antibodies were measured and a liver biopsy was performed in seven patients. RESULTS Liver injury developed within two weeks in two patients and later (30-90 days after MP) in six patients. No hepatitis-related autoantibody or hepatitis virus were found. All cases were classified as hepatocellular injury and none as cholestatic or mixed. A liver biopsy in five cases revealed centrilobular necrosis with lobular infiltrates of inflammatory cells, suggesting drug-induced acute hepatitis. The biopsy findings in another case suggested a residual stage of acute hepatitis. Only one patient showed portal expansion with periportal fibrosis, suggesting autoimmune hepatitis. All patients recovered spontaneously or with only hepatoprotective drugs, although one patient with possible autoimmune hepatitis recovered slowly. CONCLUSION Liver injury develops usually later than two weeks after MP treatment. The prognosis is good in most cases and rarely autoimmune hepatitis may be involved. Yoghurt is a fermenting milk-based dairy product that has high nutritional benefits. It exhibits not only protection against osteoporosis but also enhances gut microbiota and aids digestion. In order to improve health beneficial aspects of yoghurt, this study was aimed to synthesize gold nanoparticles (AuNPs) using seeds oil of pomegranate (Punica granatum L.) and to formulate functional yoghurt for its antioxidant and anticancer properties. The synthesized AuNPs were characterized using UV-Vis spectrophotometer, FT-IR, XRD, EDX, SEM, DLS, and Zeta potential analyzer. The photo-induced synthesis of AuNPs showed particle size and zeta potential of 70 nm and +34 mV, respectively, with unique peak at 525 nm as observed using UV-Vis spectrophotometer. The FT-IR spectrum of AuNPs showed shifts in the functional groups from 3632.27 to 541.899 cm-1, thereby indicating the presence of various functional groups in pomegranate seed oil (PSO) and PSO-capped AuNPs. The AuNPs were observed to be smooth, elongated, and rectangular in shape. The PSO-capped AuNPs based formulation of functional yoghurt revealed DPPH degradation (23.6 ± 1.5 to 62.5 ± 1.8%) and H2O2 scavenging traits (21.6 ± 1.3 to 62.8 ± 1.8%) at varied concentrations. In addition, the PSO-capped AuNPs depicted strong anticancer attributes against lung and colon cancer with the cell viability ranging from 80.3 to 25% and 83.3 to 28.4.2%, respectively. Results concluded that the antioxidative components of PSO might have reduced and formulated AuNPs-based functional yoghurt. This functional yoghurt may reveal pivotal applications in food, nutraceuticals, and pharmaceuticals, especially as antioxidant and anticancer agents.